Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov.
Most participants first33,758 with no events in either group come last2,841 to 2,860 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| Absorb BVS vs XIENCE: Number of Participants Experienced All Death/All MI | 69 of 1,286 55 of 1,300 | 1.1 points -0.5 to 2.8 | 2,586 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Target Vessel Myocardial Infarction (TV-MI) | 63 of 1,286 48 of 1,300 | 1.2 points -0.4 to 2.8 | 2,586 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Target Vessel Revascularization (TVR) | 10 of 1,286 6 of 1,300 | 0.3 points -0.3 to 1.0 | 2,586 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With ID-TVR Excluding TLR | 10 of 1,286 6 of 1,300 | 0.3 points -0.3 to 1.0 | 2,586 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Acute Success- Procedural Success (Subject Level Analysis) | 1,194 of 1,282 1,246 of 1,303 | -2.5 points -4.3 to -0.7 | 2,585 | NCT02173379 Absorb IV Randomized Controlled Trial |
| PPCS in Derivation vs PPCS in Validation: Count of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up. | 510 of 1,701 291 of 883 | -3.0 points -6.8 to 0.8 | 2,584 | NCT01873287 Predicting Persistent Postconcussive Problems in Pediatrics (5P) |
| Absorb BVS vs XIENCE: Number of Participants With Rehospitalization | 111 of 1,285 122 of 1,298 | -0.8 points -3.0 to 1.5 | 2,583 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Intervention vs No Intervention: Infant Morbidity, 2 Week Diarrhoea Prevalence | 104 of 1,323 101 of 1,256 | -0.2 points -2.3 to 1.9 | 2,579 | NCT00397150 PROMISE EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa |
| Peer Counselling for Exclusive Breastfeeding vs Standard of Care: serious adverse events | 32 of 1,323 22 of 1,256 | 0.7 points -0.5 to 1.8 | 2,579 | NCT00397150 PROMISE EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa |
| Absorb BVS vs XIENCE: Number of Participants With Repeat Coronary Arteriography | 33 of 1,282 40 of 1,295 | -0.5 points -1.8 to 0.8 | 2,577 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Rehospitalization | 178 of 1,282 178 of 1,291 | 0.1 points -2.6 to 2.8 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/All MI/ID-TLR/ID-TVR, Non TL (TVF) | 86 of 1,282 75 of 1,291 | 0.9 points -1.0 to 2.8 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Target Vessel Revascularization (TVR) | 14 of 1,282 14 of 1,291 | 0.0 points -0.8 to 0.9 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Myocardial Infarction (MI) | 70 of 1,282 56 of 1,291 | 1.1 points -0.6 to 2.8 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With ID-TVR Excluding TLR | 14 of 1,282 14 of 1,291 | 0.0 points -0.8 to 0.9 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With All Coronary Revascularization | 41 of 1,282 30 of 1,291 | 0.9 points -0.4 to 2.2 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/All MI/ID-TLR (MACE) | 80 of 1,282 67 of 1,291 | 1.1 points -0.8 to 2.9 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Death (Cardiac, Vascular, Non-cardiovascular) | 7 of 1,282 8 of 1,291 | -0.1 points -0.7 to 0.6 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/All MI | 71 of 1,282 61 of 1,291 | 0.8 points -0.9 to 2.5 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Ischemia Driven TLR (ID-TLR) | 22 of 1,282 11 of 1,291 | 0.9 points -0.0 to 1.8 | 2,573 | NCT02173379 Absorb IV Randomized Controlled Trial |
Code
curl "https://conductscience.org/api/comparisons/v1?page=143"
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=143
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT02173379-b7bc47c2",
"title": "Absorb BVS vs XIENCE: Number of Participants Experienced All Death/All MI",
"summary": "69 of 1286 against 55 of 1300; risk difference 1.1 points, 95% interval -0.5 to 2.8; NCT02173379, Absorb IV Randomized Controlled Trial",
"record": "/library/comparisons/NCT02173379-b7bc47c2",
"nct_id": "NCT02173379",
"kind": "outcome",
"participants": 2586,
"risk_difference": {
"value": 0.011347051082665385,
"lower": -0.00522327363854188,
"upper": 0.028109032145895628
},
"group_1": "69 of 1,286",
"group_2": "55 of 1,300",
"difference": "1.1 points",
"interval": "-0.5 to 2.8",
"trial_title": "Absorb IV Randomized Controlled Trial"
},
{
"id": "NCT02173379-bca9d2ec",
"title": "Absorb BVS vs XIENCE: Number of Participants With Target Vessel Myocardial Infarction (TV-MI)",
"summary": "63 of 1286 against 48 of 1300; risk difference 1.2 points, 95% interval -0.4 to 2.8; NCT02173379, Absorb IV Randomized Controlled Trial",
"record": "/library/comparisons/NCT02173379-bca9d2ec",
"nct_id": "NCT02173379",
"kind": "outcome",
"participants": 2586,
"risk_difference": {
"value": 0.01206603660724967,
"lower": -0.003655949335341066,
"upper": 0.028019915896927677
},
"group_1": "63 of 1,286",
"group_2": "48 of 1,300",
"difference": "1.2 points",
"interval": "-0.4 to 2.8",
"trial_title": "Absorb IV Randomized Controlled Trial"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "No license stated"
}
],
"next": "/api/comparisons/v1?page=144",
"request_id": "Cxrva1uqnUpNKH5J"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant